Quantum BioPharma has retained the services of MZHCI to lead a comprehensive strategic investor relations and financial communications program across all key markets. MZ will work closely with Quantum BioPharma management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment community. The campaign will highlight how Quantum BioPharma is developing a robust pipeline of products and assets focused on addressing significant unmet needs in brain disorders and alcohol health.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNTM:
- Quantum BioPharma Partners with Agencies to Boost Visibility and Investor Engagement
- Quantum BioPharma engages Enterprise Canada, Empire for PR, investor programs
- QNTM Stock trading resumes
- QNTM Stock trading halted, volatility trading pause
- Quantum BioPharma’s Licensee Celly Nutrition Plans IPO After Positive Trial Results
Questions or Comments about the article? Write to editor@tipranks.com